BRAINFERRY
Live / Allowed — Notice of allowance issued (as of 22 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99720104
- Mark type
- Word mark
- Filed
- 24 Mar 2026
- Published for opposition
- 28 Jul 2026
- Attorney of record
- QIN LI
Goods and services
- Class 005 — Pharmaceuticals: Synthetic peptides for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Medicated make-up; Medicated cosmetics; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Protein arrays for diagnosing cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents
Owner
- Shenzhen Peptide Biotechnology Co., Ltd., Shenzhen, Guangdong, CN
- Shenzhen Peptide Biotechnology Co., Ltd., Shenzhen, Guangdong, CN
Prosecution history
- 22 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jul 2026 — PUBLISHED FOR OPPOSITION
- 22 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2026 — ASSIGNED TO EXAMINER
- 24 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 24 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Mar 2026 — NEW APPLICATION ENTERED